Gabather AB (publ) (FRA:5J2)

Germany flag Germany · Delayed Price · Currency is EUR
0.0002
0.00 (0.00%)
At close: Dec 4, 2025
-99.24%
Market Cap 646.71K
Revenue (ttm) n/a
Net Income (ttm) -429.64K
Shares Out n/a
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.0002
Previous Close 0.0002
Day's Range 0.0002 - 0.0002
52-Week Range 0.0002 - 0.0394
Beta n/a
RSI 48.15
Earnings Date Nov 27, 2025

About Gabather AB

Gabather AB (publ), a pharmaceutical company, develops drug candidates for the treatment of central nervous system diseases. The company offers drugs primarily in the areas of anti-psychotics, anti-depressants and anxiolytics, and analgesics, as well as cognition-enhancing treatments, including Alzheimer’s disease. It focuses on developing GT-002, a pro-cognitive drug candidate for the treatment of Alzheimer’s disease, schizophrenia, and major depressive disorders. The company was incorporated in 2014 and is based in Södertälje, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2014
Employees 3
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 5J2
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements

News

There is no news available yet.